A Study to Assess How Itraconazole Affects the Uptake and Elimination of Capivasertib in the Body

Clinical trial NCT04712396 · COMPLETED

Trial details

NCT number: NCT04712396
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers (Intended Indication: Metastatic Patients With Triple Negative or HR+ Breast Cancer, or Hormone Sensitive Prostate Cancer)

Start date: 2021-02-01
Primary completion: 2021-03-25
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.